News North China Pharmaceutical Company.Ltd

Equities

600812

CNE000000D16

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 06/05/2024 BST			5-day change	1st Jan Change
5.27 ^CNY	-0.57%		+1.74%	-7.54%

04-25	North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-30	North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million	03-29	CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material	02-27	MT
Jizhong Energy Group Finance Co., Ltd announced that it has received CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd	12-05	CI
North China Pharmaceutical Gets Nod to Market Ampicillin API	11-20	MT
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
North China Pharmaceutical Company.Ltd(XSSC:600812) added to S&P Global BMI Index	18/09/23	CI
North China Pharmaceutical Company.Ltd(XSSC:600812) added to FTSE All-World Index	18/09/23	CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23	CI
Jizhong Energy Group Finance Co., Ltd announced that it expects to receive CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd	16/08/23	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
North China Pharma Unit Passes Compliance Inspection	31/03/23	MT
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation	13/02/23	MT
North China Pharmaceutical Company Ltd.(SHSE:600812) dropped from Shanghai Stock Exchange Health Care Sector Index	09/12/22	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22	CI
China Rolls Out New Rules to Fight Monopoly in API Drugmaking Market	19/11/21	MT
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	22/10/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News North China Pharmaceutical Company.Ltd

Equities

600812

CNE000000D16

Summary

Filters